TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20568430

Group type: EXPERIMENTAL
Intervention: Ling gui Ba fa and acupuncture at Neiguan (PC 6) and Taichong (LR 3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine acupuncture at Zusanli (ST 36), Zhongwan (CV 12), Taichong (LR 3), Neiguan (PC 6), Ganshu (BL 18) and Weishu (BL 21)
Number of subjects: 60
Study: 18156544

Group type: EXPERIMENTAL
Intervention: Mouth-to-mouth ventilation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Mouth-to-mask ventilation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Mouth-to-face shield ventilation
Number of subjects: 70
Study: 17008362

Group type: EXPERIMENTAL
Intervention: HIV behavioural intervention
Number of subjects: 1295
Study: 14521248

Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 197

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 197

Group type: COMPARATOR
Intervention: No-attention control
Number of subjects: 197
Study: 11127760

Group type: EXPERIMENTAL
Intervention: 1 mg norethindrone acetate / 10 microg ethinyl estradiol
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: 1 mg norethindrone acetate / 5 microg ethinyl estradiol
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: 0.5 mg norethindrone acetate / 2.5 microg ethinyl estradiol
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 8694219

Group type: EXPERIMENTAL
Intervention: Bupivacaine infiltration with diclofenac before surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bupivacaine infiltration with diclofenac after surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bupivacaine alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Diclofenac before surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Diclofenac after surgery
Number of subjects: 100
Study: 1534716

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg once daily)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Nifedipine retard (20 mg twice daily)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 2412034

Group type: EXPERIMENTAL
Intervention: Ketanserin (120 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31364875

Group type: EXPERIMENTAL
Intervention: Synbiotic powder containing Lactobacillus reuteri (108 CFU) and soluble fiber (4.3 g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29405863

Group type: EXPERIMENTAL
Intervention: Seminar on Compassion
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 41
Study: 28088806

Group type: EXPERIMENTAL
Intervention: Aloe sterol-supplemented yogurt
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 24559600

Group type: EXPERIMENTAL
Intervention: Ginger capsules
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Zinc sulfate capsules
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 150
Study: 22356799

Group type: EXPERIMENTAL
Intervention: Telemonitoring group (N = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (N = 50)
Number of subjects: 100
Study: 20134179

Group type: EXPERIMENTAL
Intervention: Compoglass F
Number of subjects: 98

Group type: COMPARATOR
Intervention: Twinky Star
Number of subjects: 98
Study: 18494974

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation only (Group 3)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional preparation (diamond bur + 37% phosphoric acid) (Group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Er,Cr:YSGG laser irradiation + 37% phosphoric acid (Group 2)
Number of subjects: 30
Study: 15889546

Group type: EXPERIMENTAL
Intervention: Novel red lesion detection method based on pixel classification and k-nearest neighbor classifier
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison with several different automatic systems
Number of subjects: 0

Group type: COMPARATOR
Intervention: Performance comparison with human expert
Number of subjects: 0
Study: 12366625

Group type: EXPERIMENTAL
Intervention: Individual training in strategies to rise from the floor (n = 17, mean age 81)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control chair-based flexibility intervention (n = 18, mean age 80)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Individual training in strategies to rise from the floor
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control chair-based flexibility intervention
Number of subjects: 35
Study: 10426244

Group type: EXPERIMENTAL
Intervention: Endometrial ablation
Number of subjects: 204

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 204
Study: 7538703

Group type: EXPERIMENTAL
Intervention: HCR therapy (hyperthermia combined with chemotherapy and irradiation)
Number of subjects: 243

Group type: COMPARATOR
Intervention: CR therapy (chemo-radiotherapy)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: HCR therapy
Number of subjects: 243

Group type: COMPARATOR
Intervention: CR therapy
Number of subjects: 243
Study: 2185968

Group type: EXPERIMENTAL
Intervention: Octreotide injections (100 micrograms t.i.d.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 498909

Group type: EXPERIMENTAL
Intervention: Metrizamide
Number of subjects: 51

Group type: COMPARATOR
Intervention: Meglumine ioxithalamate
Number of subjects: 51
Study: 30679336

Group type: EXPERIMENTAL
Intervention: bupivacaine 13 mg with intrathecal fentanyl 20 µg (Group BF)
Number of subjects: 56

Group type: COMPARATOR
Intervention: bupivacaine 13 mg (Group B)
Number of subjects: 56
Study: 28599674

Group type: EXPERIMENTAL
Intervention: Mobile phone application used as a job aid to ASHAs to increase coverage of MNCH services.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mobile phone application used as a job aid to ASHAs and Auxiliary Nurse Midwives (ANMs) for complicated cases.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Web interface as a job aid for medical officers and PHC staff.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Usual practice in the control area where the current level of services provided by the government will continue.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Composite index of critical, proven MNCH services.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Proportion of neonates visited by ASHAs at home within the first week of birth.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Coverage of selected MNCH services and care sought by complicated cases.
Number of subjects: 11
Study: 26074359

Group type: EXPERIMENTAL
Intervention: LT + IP (n = 6)
Number of subjects: 13

Group type: COMPARATOR
Intervention: LT (n = 7)
Number of subjects: 13
Study: 23719149

Group type: EXPERIMENTAL
Intervention: Short-term cardiac rehabilitation (CR) with dietary counseling
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (nonrehabilitation)
Number of subjects: 62
Study: 21235787

Group type: EXPERIMENTAL
Intervention: rostafuroxin 0.05 mg/d
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: rostafuroxin 0.15 mg/d
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: rostafuroxin (combined dosage arms)
Number of subjects: 435

Group type: COMPARATOR
Intervention: rostafuroxin and placebo (combined)
Number of subjects: 435
Study: 19208731

Group type: EXPERIMENTAL
Intervention: 15 g EAA/d for 3 months (supplemented treatment group)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 14
Study: 17536125

Group type: EXPERIMENTAL
Intervention: Pistachio nut diet (15% of daily caloric intake)
Number of subjects: 15
Study: 10819701

Group type: EXPERIMENTAL
Intervention: Oral clonidine hydrochloride, 0.1 mg/d
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 8632299

Group type: EXPERIMENTAL
Intervention: Triazolam (0.125 mg) preceded by ketoconazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triazolam (0.125 mg) preceded by placebo
Number of subjects: 0
Study: 1360479

Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy
Number of subjects: 9
Study: 6700072

Group type: EXPERIMENTAL
Intervention: EMT defibrillation combined with paramedic care
Number of subjects: 540

Group type: COMPARATOR
Intervention: Basic EMT and paramedic care
Number of subjects: 540
Study: 31518978

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol, 540,000 IU)
Number of subjects: 267
Study: 30646039

Group type: EXPERIMENTAL
Intervention: Active choice arm
Number of subjects: 4774

Group type: EXPERIMENTAL
Intervention: Active choice with peer comparison arm
Number of subjects: 4774

Group type: COMPARATOR
Intervention: Usual care arm
Number of subjects: 4774
Study: 26898705

Group type: EXPERIMENTAL
Intervention: Six-step model for recruitment to RCTs
Number of subjects: 60
Study: 24882450

Group type: EXPERIMENTAL
Intervention: Glucose beverage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-depleted participants
Number of subjects: 0
Study: 22245724

Group type: EXPERIMENTAL
Intervention: Flax drink (2.5 g of soluble fibers)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Flax tablets (2.5 g of soluble fibers)
Number of subjects: 44

Group type: COMPARATOR
Intervention: CONTROL (300 mL drink)
Number of subjects: 44
Study: 19914563

Group type: EXPERIMENTAL
Intervention: Various treatments including surgery, chemotherapy, molecular therapy, radiation therapy, immunotherapy, and palliative therapy
Number of subjects: 107
Study: 18401903

Group type: EXPERIMENTAL
Intervention: Oral isotretinoin 20 mg twice a day along with topical clindamycin (1%) and adapalene (0.1%) for 24 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral isotretinoin only
Number of subjects: 60
Study: 16463825

Group type: EXPERIMENTAL
Intervention: Licox
Number of subjects: 7

Group type: COMPARATOR
Intervention: Neurotrend
Number of subjects: 7
Study: 12190099

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 137

Group type: COMPARATOR
Intervention: Observation (watchful waiting)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Excluded patients
Number of subjects: 137
Study: 10633323

Group type: EXPERIMENTAL
Intervention: Teacher wellness program for two years
Number of subjects: 32
Study: 8543495

Group type: EXPERIMENTAL
Intervention: Meropenem (1 g every 8 h, infusion or bolus)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Imipenem/cilastatin (1 g every 8 h, infusion)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 232

Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Meropenem and Imipenem/cilastatin
Number of subjects: 232
Study: 1741532

Group type: EXPERIMENTAL
Intervention: Nocturnal nasal ventilation (NNV) for 3 months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard care for 3 months
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nocturnal nasal ventilation (NNV)
Number of subjects: 19
Study: 30801532

Group type: EXPERIMENTAL
Intervention: High-flow cellular EVLP system
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low-flow acellular EVLP system
Number of subjects: 16

Group type: COMPARATOR
Intervention: Controls with CIT <8 hours
Number of subjects: 16
Study: 30840384

Group type: COMPARATOR
Intervention: Daily low-dose antioxidant supplementation (vitamins and minerals) for 7.5 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26552852

Group type: EXPERIMENTAL
Intervention: Depression CAREPATH intervention (integrated depression care management into routine nursing visits)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Usual care (enhanced usual care)
Number of subjects: 306
Study: 23962141

Group type: EXPERIMENTAL
Intervention: Wakefulness (no nap)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Napping
Number of subjects: 30
Study: 23044257

Group type: EXPERIMENTAL
Intervention: Remote endarterectomy (RE)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Endovascular (ENDO)
Number of subjects: 95
Study: 19935424

Group type: EXPERIMENTAL
Intervention: Threshold Equalizing Noise (TEN) test
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: fast-PTC technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TEN test
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: fast-PTC test
Number of subjects: 20
Study: 18021288

Group type: EXPERIMENTAL
Intervention: Bowel diaries for 2 weeks
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Bowel symptom questionnaire
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Bowel diaries and symptom questionnaires
Number of subjects: 278
Study: 15796636

Group type: EXPERIMENTAL
Intervention: Personal construct group therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 42
Study: 12006142

Group type: EXPERIMENTAL
Intervention: Clickhaler (2 x 200 microg actuations)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Turbuhaler (2 x 200 microg actuations)
Number of subjects: 15
Study: 10483843

Group type: EXPERIMENTAL
Intervention: Dexamphetamine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 7805903

Group type: EXPERIMENTAL
Intervention: Doxycycline, 100 mg twice per day for 14 days
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Trimethoprim 160 mg-sulfamethoxazole 800 mg twice per day for 14 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 41
Study: 1659268

Group type: EXPERIMENTAL
Intervention: LTC4
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: LTD4
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: LTE4
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 13

Group type: COMPARATOR
Intervention: LTC4, LTD4, LTE4, Methacholine (Control for Normal Subjects)
Number of subjects: 13
Study: 7179201

Group type: EXPERIMENTAL
Intervention: Indobufen (200 mg b.i.d.)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Acenocoumarol (controlled by thrombotest)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Acenocoumarol
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Indobufen
Number of subjects: 150
Study: 30281778

Group type: EXPERIMENTAL
Intervention: Cervical traction maneuver (Amr's maneuver) for 90 seconds after placental delivery in conjunction with active management of the third stage of labor (AMTSL)
Number of subjects: 852

Group type: COMPARATOR
Intervention: Active management of the third stage of labor (AMTSL)
Number of subjects: 852
Study: 28612363

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Dental health education (DHE)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Dental health education and planning (DHE&P)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: All groups (TAU, DHE, DHE&P)
Number of subjects: 154
Study: 26537815

Group type: EXPERIMENTAL
Intervention: PVI group
Number of subjects: 440

Group type: COMPARATOR
Intervention: Conventional mean arterial pressure (control group)
Number of subjects: 440
Study: 22695241

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) for 5 postoperative days with additional oral intake ad libitum
Number of subjects: 157

Group type: COMPARATOR
Intervention: Oral nutrition alone
Number of subjects: 157
Study: 21281519

Group type: EXPERIMENTAL
Intervention: Client-centred, caseworker delivered smoking cessation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 19276766

Group type: EXPERIMENTAL
Intervention: StrataGraft skin substitute
Number of subjects: 15

Group type: COMPARATOR
Intervention: Cryopreserved cadaver allograft
Number of subjects: 15
Study: 17978968

Group type: EXPERIMENTAL
Intervention: Student teachers
Number of subjects: 59

Group type: COMPARATOR
Intervention: Associate professors
Number of subjects: 59
Study: 15738292

Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 26
Study: 12469362

Group type: EXPERIMENTAL
Intervention: nateglinide 120 mg three times daily
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: glibenclamide 5 mg once or twice daily
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: nateglinide and glibenclamide
Number of subjects: 43
Study: 11774671

Group type: EXPERIMENTAL
Intervention: 60 mmol/L nitrous oxide
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 60 mmol/L nitrous oxide with estazolam
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 40 mmol/L nitrous oxide
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 40 mmol/L nitrous oxide with estazolam
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (local anaesthesia only)
Number of subjects: 112
Study: 8140662

Group type: EXPERIMENTAL
Intervention: Ambu Twin Pump 1000
Number of subjects: 0
Study: 2643282

Group type: EXPERIMENTAL
Intervention: Slow-release nicardipine (40 mg twice a day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (twice a day)
Number of subjects: 16
Study: 4834373

Group type: EXPERIMENTAL
Intervention: Tidal volume of 5 ml/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tidal volume of 10 ml/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changing from small to large tidal volume
Number of subjects: 0
Study: 31034084

Group type: EXPERIMENTAL
Intervention: Genotypic tropism testing (GTT)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Phenotypic tropism testing (Trofile)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Both assays (GTT and Trofile)
Number of subjects: 396
Study: 27988142

Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg once daily for 10 weeks
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Filgotinib (all doses)
Number of subjects: 174
Study: 26011042

Group type: EXPERIMENTAL
Intervention: Barefoot running
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Uncushioned minimalist shoes
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cushioned minimalist shoes
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Standard running shoes
Number of subjects: 35
Study: 24165696

Group type: EXPERIMENTAL
Intervention: 0.5-mg etanercept
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 2.5-mg etanercept
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 12.5-mg etanercept
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 22204799

Group type: EXPERIMENTAL
Intervention: Melatonin (MT) 5 mg twice daily
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Tryptophan (TRP) 250 mg twice daily
Number of subjects: 42

Group type: COMPARATOR
Intervention: Omeprazole 20 mg twice daily + placebo
Number of subjects: 42
Study: 18815039

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nutrition
Number of subjects: 24
Study: 17351193

Group type: EXPERIMENTAL
Intervention: Carotid stenting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard carotid endarterectomy
Number of subjects: 0
Study: 15379414

Group type: EXPERIMENTAL
Intervention: Adult stretched penile length (SPL)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Interval SPL growth between diagnosis and adulthood
Number of subjects: 22

Group type: COMPARATOR
Intervention: Questionnaire responses (Social Adjustment Self Report Questionnaire and Hopkins Symptom Checklist)
Number of subjects: 22
Study: 11533324

Group type: EXPERIMENTAL
Intervention: Standard therapy plus acetazolamide (100 mg/kg/d) and furosemide (1 mg/kg/d)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Standard therapy plus acetazolamide and furosemide
Number of subjects: 177
Study: 9604144

Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg/2 ml ampul)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Morphine (10 mg/1 ml ampul)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tramadol and Morphine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 70
Study: 8064075

Group type: EXPERIMENTAL
Intervention: Cetirizine 15 mg twice daily for 3 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2456421

Group type: EXPERIMENTAL
Intervention: Visual-verbal feedback
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Verbal-quantitative feedback
Number of subjects: 30

Group type: COMPARATOR
Intervention: Verbal-qualitative feedback
Number of subjects: 30
Study: 31828287

Group type: EXPERIMENTAL
Intervention: 4gOBG (10 g oat-bran)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 2gOBG (3 g oat-bran)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 4gloMW (10 g oat-bran plus β-glucanase)
Number of subjects: 28

Group type: COMPARATOR
Intervention: CR (Cream of Rice)
Number of subjects: 28
Study: 30317337

Group type: EXPERIMENTAL
Intervention: Intraarticular tranexamic acid (1.5 gm)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Intravenous tranexamic acid (1.5 gm)
Number of subjects: 140
Study: 28006041

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus fluocinolone (n=223)
Number of subjects: 662

Group type: COMPARATOR
Intervention: Ciprofloxacin (n=221)
Number of subjects: 662

Group type: COMPARATOR
Intervention: Fluocinolone (n=218)
Number of subjects: 662
Study: 26589146

Group type: EXPERIMENTAL
Intervention: Worsened mental health after cessation (measured by SF-36, scored 0-100)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No change or improvement in mental health after cessation
Number of subjects: 0
Study: 23392916

Group type: EXPERIMENTAL
Intervention: 1-mA anodal transcranial direct current stimulation (tDCS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison between anodal tDCS and sham tDCS
Number of subjects: 20
Study: 21549568

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control for glucose and triglyceride levels, anticholinergic side effects, medication serum levels, cholesterol lowering medications, and pre‐study antipsychotic medications
Number of subjects: 82